Quinolines and derivatives
- (1)
- (1)
- (1)
- (224)
- (6)
- (1)
- (1)
- (40)
- (2)
- (12)
- (48)
- (1)
- (37)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (8)
- (135)
- (1)
- (10)
- (16)
- (1)
- (37)
- (1)
- (1)
- (1)
- (1)
- (1)
- (189)
- (1)
- (1)
- (17)
- (1)
- (18)
- (17)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (21)
- (26)
- (2)
- (30)
- (4)
- (6)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (5)
- (2)
- (6)
- (5)
- (1)
- (2)
- (1)
- (11)
- (1)
- (2)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (25)
- (16)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (4)
- (4)
- (8)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (2)
- (1)
- (1)
- (2)
- (1)
- (6)
- (1)
- (20)
- (1)
- (5)
- (1)
- (3)
- (5)
- (1)
- (2)
- (2)
- (2)
- (2)
- (8)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (1)
- (4)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (2)
- (5)
- (2)
- (4)
- (2)
- (3)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (4)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (3)
- (1)
- (7)
- (2)
- (1)
- (4)
- (1)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (13)
- (1)
- (1)
- (2)
- (2)
- (4)
- (3)
- (4)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (19)
- (2)
- (1)
- (2)
- (4)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (4)
- (5)
- (1)
- (2)
- (1)
- (1)
- (2)
- (4)
- (3)
- (2)
- (1)
- (9)
- (5)
- (2)
- (3)
- (3)
- (2)
- (5)
- (6)
- (3)
- (13)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (1)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (4)
- (5)
- (4)
- (3)
- (3)
- (7)
- (1)
- (1)
- (2)
- (3)
- (7)
- (5)
- (2)
- (1)
- (10)
- (1)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (2)
- (4)
- (2)
- (2)
- (6)
- (2)
- (7)
- (4)
- (3)
- (2)
- (2)
- (5)
- (2)
- (1)
- (14)
- (1)
- (1)
- (23)
- (42)
- (24)
- (18)
- (83)
- (3)
- (17)
- (3)
- (5)
- (8)
- (1)
- (6)
- (1)
- (5)
- (1)
- (6)
- (5)
- (2)
- (5)
- (2)
- (6)
- (2)
- (2)
- (4)
- (1)
- (25)
- (19)
- (71)
- (1)
- (110)
- (3)
- (1)
- (2)
- (63)
- (5)
- (1)
- (1)
- (2)
- (299)
- (2)
- (2)
- (25)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (3)
- (9)
- (3)
- (2)
- (62)
- (2)
- (5)
- (29)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (3)
- (2)
- (1)
- (1)
- (2)
- (1)
- (5)
- (4)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (5)
- (3)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (12)
- (4)
- (1)
- (5)
- (3)
- (5)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (3)
- (5)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
Filtered Search Results
Medchemexpress LLC Bromocriptine mesylate | 22260-51-1 | MFCD00069218 | 100.0% | 750.70 g/mol | C33H44BrN5O8S | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Bromocriptine mesylate is the methanesulfonate salt of bromocriptine, a semisynthetic ergot-derived dopamine D2/D3 receptor agonist used in research. It shows high affinity for D2 receptors (pKi ≈ 8.05) and is provided as both a solid and solution format for laboratory and analytical applications.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Ruboxistaurin mesylate | 192050-59-2 | MFCD09970504 | 99.9% | 564.65 | C29H32N4O6S | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Ruboxistaurin mesylate is an orally active, ATP-competitive, and selective protein kinase C beta (PKCβ) inhibitor used in preclinical research on diabetic complications, retinal/eye disorders, and cardiovascular disease. It is supplied as a solid with high reported purity and is soluble in DMSO for in vitro applications.
- Selective PKCβ inhibitor with low-nanomolar potency.
- Orally active small molecule suitable for in vitro and in vivo studies.
- High reported purity (~99.9%) for research applications.
- Solid form, orange to red color, easy handling and storage.
- Soluble in DMSO at 50 MG/ML (88.55 mM); ultrasonic assistance may be required.
- Storage guidance: 4°C sealed; in solvent: -80°C (6 months), -20°C (1 month).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Danofloxacin mesylate | 119478-55-6 | MFCD00673687 | 99.9% | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone used as a veterinary drug. It exhibits broad-spectrum bactericidal activity primarily by inhibiting bacterial DNA gyrase and also functions as a substrate for ATP-dependent efflux transporters such as P-gp and MRP2.
- Used as a veterinary drug
- Broad-spectrum bactericidal activity
- Inhibits bacterial DNA gyrase
- Substrate for ATP-dependent efflux transporters (P-gp and MRP2)
- Targets P-glycoprotein and bacterial components
- Involves membrane transporter/ion channel and anti-infection mechanisms
- Effective against bovine bacterial respiratory pathogens
- Demonstrates asymmetric transport across Caco-2 cells
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Danofloxacin mesylate | 119478-55-6 | 99.9% | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Danofloxacin mesylate is a fluoroquinolone used as a veterinary drug. It exhibits a broad spectrum of bactericidal activity, primarily by inhibiting the DNA cycloenzyme of bacteria. Additionally, it acts as a substrate for ATP-dependent efflux transporters (P-gp and MRP2).
- Used as a veterinary drug
- Exhibits a broad spectrum of bactericidal activity
- Primarily inhibits bacterial DNA cycloenzyme
- Acts as a substrate for ATP-dependent efflux transporters (P-gp and MRP2)
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Ergi-USU-6 mesylate | 2756327-67-8 | 95.0% | C14H18N4O4S | 10MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ERGi-USU-6 mesylate is a research-grade small-molecule inhibitor of ERG and RIOK2 with reported cellular potency (IC50 ≈ 0.13-0.17 μM in VCaP cells). The methanesulfonate salt is supplied as a solid with a reported purity of 95% and is intended for in vitro and preclinical research use.
- Inhibits ERG and RIOK2 with submicromolar cellular potency.
- Demonstrates antiproliferative activity in ERG-positive prostate cancer models.
- Supplied as a mesylate salt for improved handling and stability.
- High reported purity suitable for biochemical and cell-based assays.
- Solid form with defined cold-storage recommendations for sample integrity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Bromocriptine mesylate | 22260-51-1 | 99.90% | 200 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Bromocriptine mesylate is a potent dopamine D2/D3 receptor agonist, binding to the D2 dopamine receptor with a pKi of 8.05. It is permeable to the blood-brain barrier. This compound also acts as a strong inhibitor of brain nitric oxide synthase (NOS) with an IC50 of 10±2 μM for purified neuronal NOS, and poorly inhibits inducible macrophage NOS (IC50>100 μM). Additionally, it is a potent inhibitor of CYP3A4, with a calculated IC50 value of 1.69 μM.
- Potent dopamine D2/D3 receptor agonist
- Permeable to the blood-brain barrier
- Strong inhibitor of brain nitric oxide synthase (NOS)
- Potent inhibitor of CYP3A4
- Shows anti-immobility action in mice (in FST and TST)
- Potentiates the anti-immobility action of MPE
- Decreases static mechanical allodynia (SMA) score in rats
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Deferoxamine (mesylate) | 138-14-7 | 99.8% | 20 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Deferoxamine mesylate is an iron chelator that binds to Fe(III) and other metal cations. It is widely used to reduce iron accumulation and deposition in tissues. This compound upregulates HIF-1α levels with good antioxidant activity, shows anti-proliferative activity, and can induce apoptosis and autophagy in cancer cells. It is applicable in studies of diabetes, neurodegenerative diseases, anti-cancer research, and anti-COVID-19 research.
- Binds to Fe(III) and other metal cations
- Reduces iron accumulation and deposition in tissues
- Upregulates HIF-1α levels
- Exhibits good antioxidant activity
- Shows anti-proliferative activity
- Induces apoptosis and autophagy in cancer cells
- Applicable in studies related to diabetes, neurodegenerative diseases, anti-cancer research, and anti-COVID-19 research
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Deferoxamine mesylate (Standard) | 138-14-7 | 99.47% | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Deferoxamine mesylate (Standard) is the analytical standard for Deferoxamine mesylate, intended for research and analytical applications. It is an iron chelator, binding to Fe(III) and other metal cations, and is widely used to reduce iron accumulation and deposition in tissues. It also upregulates HIF-1α levels with good antioxidant activity, shows anti-proliferative activity, and can induce apoptosis and autophagy in cancer cells. This compound can be used in studies related to diabetes, neurodegenerative diseases, anti-cancer research, and anti-COVID-19 research.
- The compound is an analytical standard, serving as a reference standard for assays.
- Commonly employed in qualitative, quantitative, and methodological research experiments such as HPLC, GC, and MS.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
TARGETMOL CHEMICALS INC OBATOCLAX MESYLATE 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Obatoclax Mesylate (GX15-070) is a Bcl-2 antagonist (Ki 0.22 uM) and can induce apoptosis with up-regulation of Bim induced cytochrome c release and activation of caspase-3. purity: 99%
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Firmonertinib mesylate | 2130958-55-1 | 100.0% | 664.70 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Firmonertinib mesylate is an orally active, mutant-selective, and blood-brain barrier penetrant EGFR inhibitor. It inhibits EGFR active mutations as well as the T790M acquired resistant mutation. It has potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins mutation.
- Orally active
- Mutant-selective
- Blood-brain barrier penetrant EGFR inhibitor
- Inhibits EGFR active mutations and T790M acquired resistant mutation
- Potential for research of cancer diseases, especially advanced NSCLC with EGFR ex20ins mutation
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Dihydroergocristine mesylate | 24730-10-7 | MFCD00153792 | ≥98.0% | 707.84 | C36H45N5O8S | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Dihydroergocristine mesylate is a research reagent reported to act as a γ-secretase inhibitor; it reduces production of amyloid-β peptides and binds directly to γ-secretase and nicastrin. It is supplied as the mesylate salt for use in neuroscience and Alzheimer's disease research.
- Acts as a γ-secretase inhibitor.
- Reduces production of amyloid-β peptides.
- Binds directly to γ-secretase and nicastrin.
- Supplied as the mesylate salt.
- Available in small research quantities suitable for analytical or in-vitro studies.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Methysergide maleate salt solid | 129-49-7 | MFCD00083185 | 2MG
Methysergide maleate salt solid | Mol Wt: 469.53 | 129-49-7 | MFCD00083185 | 2MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 383907-43-5 | Medchem Express | NSC 663284 | 2mg | 446254896 | HY-100034 | MFCD08276924 | 321.76 | C15H16ClN3O3
Ambeed | 4-Bromo-25-dichlorobenzoic acid | 250mg | 525031901 | A128739 | 885532-41-2 | MFCD08444534 | 269.900 | C7H3BrCl2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Aobchem 2 2-Difluoroethylmethane sulfonate | ≥95% | CAS 163035-65-2 | C3H6F2O3S | 5g
2 2-Difluoroethylmethane sulfonate | ≥95% | CAS 163035-65-2 | C3H6F2O3S | 5g
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Ruboxistaurin mesylate | 192050-59-2 | 99.9% | 564.65 g/mol | C29H32N4O6S | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Ruboxistaurin mesylate is an orally active, selective, ATP-competitive protein kinase C beta (PKCβ) inhibitor used in preclinical research on diabetic complications, retinal disorders, and cardiovascular conditions. Supplied as the mesylate salt, it is an orange-to-red solid with molecular formula C29H32N4O6S and molecular weight 564.65 g/mol.
- Selective PKCβ inhibition with low nanomolar potency (IC50 ~4.7-5.9 nM).
- Mesylate salt form for improved stability and handling.
- High purity (99.87%) suitable for research applications.
- Orange-to-red solid, convenient for solid-state storage.
- Molecular formula C29H32N4O6S and molecular weight 564.65 g/mol.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More